Maksim Lyubomudrov

Dr. Maksim Lyubomudrov

Cell pathology in critical state, V.A. Negovsky Scientific Research Institute of General Reanimatology, Moscow, Moskva, Russia
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Anastasia S. BabkinaAnastasia S. Babkina
Anastasia S. Babkina
MLMaksim Lyubomudrov
Maksim Lyubomudrov
MGMikhail A. Golubev
Mikhail A. Golubev
MPMikhail Pisarev
Mikhail Pisarev
Arkady GolubevArkady Golubev
Arkady Golubev
Since the discovery of the neuron-specific protein by Moore and McGregor in 1965, tens of thousands of studies have investigated the basic and applied significance of neuron-specific enolase (NSE). This promising biomarker, according to many researchers, has not found widespread use in clinical practice, particularly in acute cerebrovascular accidents. Moreover, the several studies refuting the usefulness of serum NSE measurement in critically ill patients leads us to consider the reasons for such contradictory conclusions. In this article, we have analyzed the main directions in the study of NSE and expressed our perspective on the reasons for the contradictory results and the difficulties in implementing the results of these studies in clinical practice. In our opinion, the method of the enzyme-linked immunosorbent assay (ELISA) used in the majority of the studies is inappropriate for the evaluation of NSE as a marker of central nervous system damage, because it does not allow for the differentiation of heterodimers of enolases and the assessment of the enzymatic activity of this group of enzymatic proteins. Therefore, the methodological approach for the evaluation of NSE (γγ-enolase) as a biomarker needs to be elaborated and improved. Furthermore, the specificity of the applied research methods and the appropriateness of the continued use of the term “neuron-specific enolase” must be addressed.

13 March 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
VAViktoriya Vitalievna Antonova
Viktoriya Vitalievna Antonova
Denis N. SilachevDenis N. Silachev
Denis N. Silachev
Egor PlotnikovEgor Plotnikov
Egor Plotnikov
IPIrina B. Pevzner
Irina B. Pevzner
Elmira YakupovaElmira Yakupova
Elmira Yakupova
OGOleg Aleksandrovich Grebenchikov
Oleg Aleksandrovich Grebenchikov
This is the first in vivo study to investigate the neuroprotective effects of krypton on focal cerebral ischemia. The aim of the study was to analyze the effect of 2 h of inhalation of a krypton–oxygen mixture (Kr 70%/O2 30%) on the recovery of neurological functions and the degree of brain damage in rats after photoinduced ischemic stroke (PIS) and to investigate the possible mechanisms responsible for this neuroprotection. Experiments were performed on male Wistar rats weighing 250–300 g (n = 32). Animals were randomized into four groups. Two groups (n = 20) underwent photoinduced ischemic stroke, followed by 2 h of inhalation of krypton–oxygen mixture consisting of Kr 70%/O2 30% or a nitrogen–oxygen breathing mixture consisting of N2 70%/O2 30%, followed by neurological examinations on days 3 and 7. The other two groups (n = 12) received only gas mixtures of the same concentration and exposure duration as in those in the PIS groups, then Western blot analysis of the potential molecular mechanisms was performed. The results of the study show that treatment with the krypton–oxygen mixture consisting of Kr 70%/O2 30% improves the neurological status on day 7 of observation, reduces the lesion volume according to the MRI examination and the number of Iba-1- and caspase-3-positive cells in the damaged area, promotes the activation of neoangiogenesis (an increase in the von Willebrand factor), and reduces the penumbra area and the number of NeuN-positive cells in it on day 14 of observation. Inhalation of the krypton–oxygen mixture also significantly increases the levels of phosphorylated AKT kinase (protein kinase B) and glycogen synthase kinase 3b (pGSK3b) and promotes the expression of transcription factor Nrf2, which was accompanied by the lowered expression of transcription factor NFkB (p50). Thus, we showed pronounced neuroprotection induced by krypton inhalation after stroke and identified the signaling pathways that may be responsible for restoring neurological functions and reducing damage.

9 May 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
Anastasia S. BabkinaAnastasia S. Babkina
Anastasia S. Babkina
Mikhail Ya. YadgarovMikhail Ya. Yadgarov
Mikhail Ya. Yadgarov
MLMaksim Lyubomudrov
Maksim Lyubomudrov
Irina OstrovaIrina Ostrova
Irina Ostrova
AVAlexey Volkov
Alexey Volkov
Arkady GolubevArkady Golubev
Arkady Golubev
Despite the enormous interest in COVID-19, there is no clear understanding of the mechanisms underlying the neurological symptoms in COVID-19. Microglia have been hypothesized to be a potential mediator of the neurological manifestations associated with COVID-19. In most existing studies to date, morphological changes in internal organs, including the brain, are considered in isolation from clinical data and defined as a consequence of COVID-19. We performed histological immunohistochemical (IHC) studies of brain autopsy materials of 18 patients who had died from COVID-19. We evaluated the relationship of microglial changes with the clinical and demographic characteristics of the patients. The results revealed neuronal alterations and circulatory disturbances. We found an inverse correlation between the integral density Iba-1 (microglia/macrophage-specific marker) IHC staining and the duration of the disease (R = −0.81, p = 0.001), which may indicate a reduced activity of microglia and do not exclude their damage in the long-term course of COVID-19. The integral density of Iba-1 IHC staining was not associated with other clinical and demographic factors. We observed a significantly higher number of microglial cells in close contact with neurons in female patients, which confirms gender differences in the course of the disease, indicating the need to study the disease from the standpoint of personalized medicine.

24 June 2023 in General Reanimatology
Verified
Journal Article
Open access
PDF file
IOIrina Vasilievna Ostrova
Irina Vasilievna Ostrova
Anastasia S. BabkinaAnastasia S. Babkina
Anastasia S. Babkina
MLMaksim Lyubomudrov
Maksim Lyubomudrov
AGAndrey Grechko
Andrey Grechko
Arkady GolubevArkady Golubev
Arkady Golubev
Better understanding of ischemic brain injury mechanisms is important for the development and improvement of diagnostic and therapeutic modalities for management of ischemic stroke. As experimental studies are on demand, there’s a need for relevant models of focal brain lesions. Photochemically induced thrombosis remains one of the most popular models of ischemic stroke.The purpose of the reviewis to consider the pathogenesis and applicational relevance of the photochemical thrombosis in ischemic stroke modeling.Material and methods.The information was searched using PubMed and Google Scholar databases and keywords «photothrombotic stroke» without language restrictions. 74 papers out of more than 600 sources were found the most relevant for the purpose of this review and selected for the analysis. Of these, more than 50% have been published in the last five years. The criterion for excluding a source was an inconsistency with the objectives of the review and low information content.Results.We outlined a variety of features in modeling photothrombotic stroke, analyzed the advantages and disadvantages of the model, presented data on current method’s modifications, as well as approaches to evaluation of brain lesions in ischemic stroke induced by photothrombosis, and summarized information about the mechanisms of brain damage induced in this model.Conclusion.Several advantages of the photothrombotic stroke model, such as low invasiveness, high reproducibility, inherent control of brain infarction volume and low mortality, determine its active use in experimental studies of ischemic stroke. Pathological processes in the brain modeled by photochemical thrombosis are similar to the processes occurring in acute ischemic cerebral circulation events. Therefore, this model provides insights into cellular and molecular mechanisms of ischemic brain damage, and can be used for developing novel therapeutic approaches for management of ischemic stroke.

31 January 2025 in General Reanimatology
Verified
Journal Article
Open access
PDF file
Arkady GolubevArkady Golubev
Arkady Golubev
MLMaksim Lyubomudrov
Maksim Lyubomudrov
Anastasia S. BabkinaAnastasia S. Babkina
Anastasia S. Babkina
ZTZoya Tsokolaeva
Zoya Tsokolaeva
ЗЦЗ. И. Цоколаева
З. И. Цоколаева
Aim. To identify personalized morphological neuronal phenotypes based on the distribution pattern of the neuronal protein NeuN in the cerebral cortex layers.Materials and Methods. A histologic study of the cerebral cortex was performed in rats (N=10). Tissue sections were stained with hematoxylin and eosin, and the neuronal nuclear protein NeuN was visualized by immunohistochemical staining. Analysis was performed by microscopy and image analysis software.Results. NeuN immunohistochemical staining revealed distinct localization and intensity patterns within cortical neurons. Contrary to the definition of NeuN as a nuclear neuronal protein, its localization was observed in both the nucleus and cytoplasm in most neurons. The following neuronal phenotypes were identified based on NeuN staining patterns: 1) Neurons with stained nuclei but unstained cytoplasm; 2) Neurons with stained cytoplasm but unstained nuclei; 3) Neurons with stained nuclei and cytoplasm; 4) Fully stained neurons with no visible nuclei; 5) Neurons with stained processes (dendrites/axons). A significant difference was found between mean intensity of NeuN-positive neurons depending on the localization in the layers of the cerebral cortex.Conclusion. Given the critical biological role of NeuN, the identified neuronal phenotypes based on NeuN localization warrant further research as they may reflect the functional states of neurons. The interpretation of the absence of NeuN staining as a marker of neuronal damage is not scientifically justified. Future studies using NeuN immunohistochemical staining should consider not only the total number of NeuN-positive neurons, but also their distinct phenotypes.

16 February 2026 in General Reanimatology
Verified
Journal Article
Open access
PDF file
EBEkaterina Boeva
Ekaterina Boeva
SKSergei Nikolaevich Kalabushev
Sergei Nikolaevich Kalabushev
LVLydia Aleksandrovna Varnakova
Lydia Aleksandrovna Varnakova
MLMaksim Lyubomudrov
Maksim Lyubomudrov
ZTZoya Tsokolaeva
Zoya Tsokolaeva
IRIvan Aleksandrovich Ryzhkov
Ivan Aleksandrovich Ryzhkov
Cardiac arrest remains one of the leading causes of death worldwide. Even with successful resuscitation, patient outcomes are often poor due to post-resuscitation syndrome, which includes cerebral hypoxia, myocardial dysfunction, microcirculatory disorders, coagulation abnormalities, and systemic inflammation. Argon, an inert noble gas, has neuroprotective and cardioprotective properties, making it a promising candidate for early post-resuscitation therapy. The aim of the study was to evaluate the organoprotective properties of an argon-oxygen mixture when inhaled in the early post-resuscitation period for 2 hours after asphyxial circulatory arrest in rats. Materials and methods. A prospective randomized controlled experimental study was conducted on male Wistar rats ( n = 43) using an asphyxial circulatory arrest model. The animals were divided into three groups: sham-operated (SO, n = 12), circulatory arrest with resuscitation (CAR, n = 13), and circulatory arrest with resuscitation and two-hour inhalation of a 70%/30% argon-oxygen mixture in the post-resuscitation period (CAR + iAr, n = 18). Hemodynamics, microcirculation, blood gas composition, coagulation (low-frequency piezothromboelastography), neurological status, and biomarkers of organ damage were evaluated. Beclin-1 and caspase-3 expression was analyzed immunohistochemically. Results. Argon inhalation did not have a significant effect on systemic hemodynamics, but it was accompanied by improved tissue oxygenation and metabolism: a decrease in blood lactate ( p = 0.043), an increase in the p/F oxygenation index ( p = 0.001), and stabilization of microcirculation variability (Kv, σ). Statistically significantly increased expression of the Beclin-1 protein in the lungs, myocardium, and hippocampus reflected activation of autophagy. In the CAR + iAr group, there was an improvement in neurological status compared to CAR ( p = 0.02), a decrease in serum neuron-specific enolase ( p = 0.011), and a decrease in the number of caspase-3-positive cells ( p = 0.011), indicating a reduction in apoptosis and damage to the nervous tissue. Argon had a moderate anticoagulant and antiplatelet effect (coagulation drive intensity — CDI, and maximum clot firmness-MCF reduction), while maintaining normal processes of clot retraction and lysis. The electrophysiological parameters of the heart (QRS, QTc) varied within the physiological range, indicating the absence of pro-arrhythmic effects in argon. Conclusion. Early inhalation of argon-oxygen mixture after circulatory arrest has a multisystem protective effect: improves oxygenation and microcirculation, promotes activation of autophagy mechanisms in vital organs, reduces the severity of neuronal damage, and modulates blood clotting in some measure. Argon can be considered a promising therapeutic agent for post-resuscitation syndrome. Further clarification is needed to assess argon’s molecular mechanisms of action and long-term outcomes after its use.